NeuroVasc Secures $34M in Funding


NeuroVasc Technologies, Inc., an Irvine, Calif.-based developer of novel catheter-based technologies, raised $34m in funding.

The Wego Group made the investment.

The funding has been applied initially towards supporting clinical trials for the company’s novel stent-retriever, designed to treat patients suffering an acute ischemic stroke, in all major markets including Japan, EU, US, and China.

With a focus on novel catheter-based technologies to treat neurovascular disease, NeuroVasc has developed a comprehensive portfolio development strategy to bring differentiated tools to the INR community to facilitate broader treatment options for patients suffering stroke and other neurovascular diseases. The strategic partnership marks a major step forward for NeuroVasc Technologies in bringing a full neurovascular platform to market. The company’s portfolio of devices is aimed to help neurointerventional physicians more efficiently and effectively treat neurovascular disease.

NeuroVasc is led by Jim Ma, CEO.



Join the discussion